Blue Crest Capital Management LTD Stryker Corp Transaction History

Blue Crest Capital Management LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$246.13 - $285.47 $196,904 - $228,376	800 New	800 $228,000
Q4 2019 Feb 14, 2020	SELL	$197.98 - $220.53 $453,176 - $504,793	-2,289 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$205.4 - $221.82 $470,160 - $507,745	2,289 New	2,289 $495,000
Q2 2019 Aug 14, 2019	SELL	$180.24 - $205.58 $649,404 - $740,704	-3,603 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$152.46 - $198.0 $549,313 - $713,394	3,603 New	3,603 $712,000
Q4 2018 Feb 14, 2019	SELL	$145.0 - $178.65 $2.27 Million - $2.8 Million	-15,674 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$163.25 - $177.68 $2.56 Million - $2.78 Million	15,674 New	15,674 $2.79 Million
Q1 2018 May 15, 2018	SELL	$148.01 - $168.91 $17 Million - $19.4 Million	-114,711 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$143.51 - $159.74 $16.5 Million - $18.3 Million	114,711	114,711 $17.8 Million

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $148B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.